Stocks and Investing
Stocks and Investing
Wed, July 13, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Olivia Brayer Initiated (ALNY) at Hold and Held Target at $175 on, Jul 13th, 2022
Olivia Brayer of Cantor Fitzgerald, Initiated "Alnylam Pharmaceuticals, Inc." (ALNY) at Hold and Held Target at $175 on, Jul 13th, 2022.
Olivia has made no other calls on ALNY in the last 4 months.
There are 7 other peers that have a rating on ALNY. Out of the 7 peers that are also analyzing ALNY, 4 agree with Olivia's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Debjit Chattopadhyay of "Guggenheim" Downgraded from Strong Buy to Hold on, Monday, June 27th, 2022
- Mani Foroohar of "SVB Leerink" Maintained at Hold with Increased Target to $98 on, Wednesday, June 15th, 2022
- Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $170 on, Friday, April 29th, 2022
- Gary Nachman of "BMO Capital" Maintained at Hold with Decreased Target to $166 on, Friday, April 29th, 2022
These are the ratings of the 3 analyists that currently disagree with Olivia
- Myles Minter of "William Blair" Initiated at Buy on, Tuesday, June 7th, 2022
- Patrick Trucchio of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $430 on, Monday, May 2nd, 2022
- David Lebowitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $211 on, Friday, April 29th, 2022
Contributing Sources